179 results on '"Itkin, Zina"'
Search Results
2. Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex
3. High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
4. Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma
5. Deep learning identifies synergistic drug combinations for treating COVID-19
6. Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
7. A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroids.
8. A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
9. A Comprehensive Collection of Pain and Opioid Use Disorder Compounds for High-Throughput Screening and Artificial Intelligence-Driven Drug Discovery.
10. A comprehensive collection of pain and addiction targets and compounds library for high throughput screening and AI-driven drug discovery
11. FIGURE 3 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
12. Supplementary Table S1 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
13. Supplementary Figure S6 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
14. Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
15. FIGURE 6 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
16. FIGURE 5 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
17. FIGURE 4 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
18. FIGURE 8 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
19. FIGURE 7 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
20. FIGURE 2 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
21. FIGURE 1 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
22. Data from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
23. Human Pluripotent Stem Cells for High-Throughput Drug Screening and Characterization of Small Molecules
24. Correction to: Human Pluripotent Stem Cells for High-Throughput Drug Screening and Characterization of Small Molecules
25. Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma
26. High-Throughput Screening for Drug Combinations
27. Abstract LB315: Inhibition of FGFR4 with futibatinib combined with inhibition of IGF1R, Src family kinases, or AKT is synergistic against rhabdomyosarcoma
28. High-throughput Approaches to Uncover Synergistic Drug Combinations in Leukemia
29. mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer
30. High-throughput Approaches to Uncover Synergistic Drug Combinations in Leukemia
31. Application of temperature-responsive HIS-tag fluorophores to differential scanning fluorimetry screening of small molecule libraries
32. Additional file 3 of High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
33. Additional file 4 of High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
34. Additional file 1 of High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
35. A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike
36. Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
37. Identifying Small Molecule Compounds that Have Synergistic Effects With Cisplatin and Other Platinum Drugs Using High Throughput Matrix Screening
38. Comparison of Compound Administration Methods in Biochemical Assays: Effects on Apparent Compound Potency Using Either Assay-Ready Compound Plates or Pin Tool–Delivered Compounds
39. A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
40. mTOR Inhibition Overcomes RSK3-mediated Resistance to BET Inhibitors in Small Cell Lung Cancer
41. Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection
42. A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike
43. A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
44. Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein
45. Inhibiting SARS‐CoV‐2 infection with lysosomal alkalizers
46. Deep learning identifies synergistic drug combinations for treating COVID-19
47. Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
48. Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
49. Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
50. The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.